Internal Medicine, Endocrinology, Diabetes, & Metabolism · Albany, NY
NPI
1275530537
Since 2005
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1365 Washington Ave, Ste 300
Albany, NY, 12206
Phone (518) 489-4704
Groups this clinician bills Medicare through
Medicare paid, 2024
$61K
1,285 services
Medicare patients, 2024
631
Average age 73
Drug cost, 2024
$4.0M
8,436 prescriptions
Company payments, 2025
$2,271
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gary Bakst was code 99214 (office e&m - established), 808 times for 449 patients. In total Gary Bakst billed 1,285 services in 14 codes, and Medicare paid $61K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 808 | 449 | $60.74 | $49K |
| 77080 Standard X-ray | Office | 164 | 164 | $9.02 | $1,480 |
| 99213 Office E&M - Established | Office | 161 | 142 | $41.07 | $6,612 |
| 95251 Test - Miscellaneous | Office | 76 | 43 | $22.84 | $1,735 |
| 99211 Office E&M - Established | Office | 25 | 21 | $6.63 | $166 |
| 76536 Ultrasound - Nonspecific | Office | 22 | 22 | $22.61 | $497 |
By year: 2022 $71K for 1,221 services; 2023 $73K for 1,316 services; 2024 $61K for 1,285 services.
Medicare prescription drug claims, 2024
In 2024, the drug Gary Bakst prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,077 prescriptions and refills. In total Gary Bakst wrote 8,436 Medicare prescriptions that cost $4.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,077 | 2,959 | 288 | $20K |
| Ozempic Semaglutide | 540 | 1,137 | 125 | $1.1M |
| Synthroid Levothyroxine Sodium | 411 | 1,180 | 120 | $34K |
| Metformin Hcl Generic | 394 | 1,146 | 117 | $2,567 |
| Jardiance Empagliflozin | 355 | 885 | 93 | $507K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 334 | 863 | 120 | $75K |
| Atorvastatin Calcium Generic | 308 | 907 | 99 | $3,524 |
| Rosuvastatin Calcium Generic | 227 | 665 | 77 | $3,453 |
| Novolog Flexpen Insulin Aspart | 191 | 452 | 71 | $77K |
| Mounjaro Tirzepatide | 142 | 257 | 33 | $273K |
| Amlodipine Besylate Generic | 132 | 394 | 43 | $753 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 129 | 323 | 50 | $16K |
| Trulicity Dulaglutide | 128 | 251 | 37 | $245K |
| Metformin Hcl Er Metformin Hcl | 121 | 354 | 40 | $1,300 |
| Pioglitazone Hcl Generic | 120 | 346 | 41 | $1,777 |
Brand drugs: 3,559 claims; generic drugs: 4,393 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gary Bakst $2,271 ($2,271 in general payments such as food, travel and fees) from 20 companies. The largest payer was Lilly USA, LLC with $325.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 18 | $325 |
| Amgen Inc. AMGN | 15 | $237 |
| Insulet Corporation PODD | 9 | $217 |
| Dexcom, Inc. DXCM | 11 | $197 |
| Sanofi-Aventis U.S. LLC SNY | 6 | $191 |
| Novo Nordisk Inc NVO | 8 | $163 |
| Abbott Laboratories ABT | 8 | $142 |
| Mannkind Corporation MNKD | 6 | $118 |
| Ascendis Pharma Endocrinology Inc ASND | 4 | $111 |
| Radius Health, Inc. | 4 | $99.81 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.